Spikner Pamela L.
SEC CIK 2012329 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BDX | Becton Dickinson | SVPController, Chief Acct Off | 3,323 | — | — | 3 | 2025-11-26 | 2026-03-02 |
Most active insiders at BDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polen Thomas E Jr | COB, CEO, Pres, Dir | — | $1.17M |
| 2 | Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | — | $784.2K |
| 3 | Goette Roland | EVP, Pres, EMEA | — | $440.9K |
| 4 | SCOTT BERTRAM L | Dir | — | $212.3K |
| 5 | Feld Michael | EVP, Pres, Life Sciences | — | $167.4K |
| 6 | Menziuso Peter | EVP, Pres, BDI | — | — |
| 7 | Roque Vitor | Interim CFO | — | — |
| 8 | Spikner Pamela L. | SVPController, Chief Acct Off | — | — |
| 9 | Shan David | EVP, Chief ISC Off | — | — |
| 10 | Waldstreicher Joanne | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | BDX | Becton Dickinson | Spikner Pamela L. | CAO, SVP Ctrl | A - Grant | $0.00 | +931 | 3,323 | +39% | $0 | |
| 2026-01-23 | 2026-01-21 | BDX | Becton Dickinson | Spikner Pamela L. | CAO, SVP Ctrl | F - Tax | $0.00 | -84 | 1,832 | -4% | $0 | |
| 2025-12-01 | 2025-11-26 | BDX | Becton Dickinson | Spikner Pamela L. | SVPController, Chief Acct Off | A - Grant | $0.00 | +1,234 | 1,916 | +181% | $0 |
Purchase Sale Sale after option exercise All abbreviations